ORIGINAL RESEARCH article
Front. Oncol.
Sec. Breast Cancer
Evaluation of the Accuracy of Cone-Beam CT–Based Dose Calculation for Target Volumes and Organs at Risk in Left-Sided Breast Cancer Radiotherapy
Provisionally accepted
- Subei People's Hospital of Jiangsu Province, Yangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective To evaluate the feasibility and accuracy of cone-beam CT (CBCT) images with HU–relative electron density (HU-RED) correction for dose calculation in left-sided breast cancer radiotherapy. Methods Twenty postoperative patients receiving adjuvant radiotherapy at Subei People's Hospital of Jiangsu Province (Yangzhou, China) from January 2022 to December 2024 were retrospectively enrolled. A patient-specific HU-RED calibration curve was generated using an improved density override method. Treatment plans created on planning CT (pCT) were transferred to CBCT for dose recalculation with identical optimization parameters. Dosimetric parameters of the planning target volume (PTV) and organs at risk (OARs) were compared. Two-dimensional gamma analysis was performed to assess dose consistency. Equivalence between CBCT-and pCT-based dose calculations was further evaluated using the two one-sided tests (TOST), Lin's concordance correlation coefficient (CCC), intraclass correlation coefficient (ICC), and Bland–Altman analysis. Results Differences in PTV dosimetric indices (D2, D50, D98, Dmean, HI, CI) between CBCT-and pCT-based plans were small, with mean deviations <1.3% and no statistically significant differences (P > 0.05). OAR parameters, including cardiac Dmean, V20, V30, V50 and lung Dmean, V20, V30, also showed minimal variation (<1.5%), with the largest deviation observed in cardiac V20 (2.1% in a single case). Gamma analysis revealed high agreement between both plans, with passing rates exceeding 90% for both the 3%/3 mm and 2%/2 mm criteria. Equivalence testing demonstrated statistical equivalence between CBCT-and pCT-based dose calculations for all PTV parameters and most OAR metrics. All 90% confidence intervals fell entirely within predefined equivalence margins (Δ), and all TOST P-values were <0.05. Lin's CCC and ICC(A,1) exceeded 0.96 for all parameters, indicating excellent consistency, while Bland–Altman analyses showed minimal bias and narrow limits of agreement. Conclusion CBCT images corrected with HU-RED calibration can achieve highly consistent dose calculation results compared with pCT in left-sided breast cancer radiotherapy. This approach is applicable for clinical dose verification, and, with the integration of artificial intelligence and deep learning, CBCT holds promise for future adaptive radiotherapy.
Keywords: breast cancer, Cone-beam CT, dosimetric evaluation, Organs at Risk, Radiotheapy
Received: 15 Dec 2025; Accepted: 16 Feb 2026.
Copyright: © 2026 Hou, Bai, Xiaoxiao, Dai, Jiang, Hou and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xiaoxiao Hou
Xiaoxiao Hou
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.